From: The human microbiome: redefining cancer pathogenesis and therapy
Cancer type | Microbes associated with increased risk | Microbes associated with decreased risk | References |
---|---|---|---|
Colorectal cancer | Streptococcus gallolyticus, Bacteroides fragilis, Solobacterium moorei, Fusobacterium nucleatum | Â | |
Pancreatic cancer | Porphyromonas, A. Actinomycetemcomitans Ascomycota, Basidiomycota, Malassezia | Â | |
Brain cancer /glioma | Enrerobacteriaceae, Fusobacterium, Akkermansia | Â | |
Gastric cancer | Helicobacter pylori | Â | [209] |
Ovarian cancer | Neisseria gonorrhoeae or Chlamydia trachomatis, Bacteriodete, Firmicutes | Â | |
Lung cancer | Actinomyces, Haemophilus, Streptococcus | Â | |
Breast cancer | Lactobacilli, Bacteroide fragilis, Clostridia, Fusobacterium nucleatum, Escherichia coli | Lactobacillus helvecticus R389, Lactobacillus casei, Lactobacillus acidophilus | [127] |
Cervical | Fusobacterium spp, Mycoplasma genitalium, Chlamydia trachomatis | Â | |
Glioblastoma | Peptostreptococcaceae, Eubacterium brachy | Ruminococcaceae, Anaerostipes, Faecalibacterium, LachnospiraceaeUCG004, Phascolarctobacterium, Prevotella7, Streptococcus | |
Larynx | Fusobacterium nucleatum, Streptococcus spp, Prevotella spp, Helicobactor pylori | Streptococcus spp | |
Prostate | Cutibacterium acnes, Shewanella, Microbacterium sp, Escherichia coli, Streptococcus anginosusi, Propionibacterium acnesi | Botulinum toxin A, Staphylococcus aureus | |
Oral squamous cell carcinoma | Capnocytophaga gingivalis, Fusobacterium nucleatum, Carnobacterium spp, Tannerella spp, Parvimonas spp, Filifactor spp, Candida | Lactobacillus plantarum | |
Bladder | Prevotella spp, Alistipes spp, Barnesiella spp, Parabacteroides spp, Lachnospiracea_incertae_sedis, Staphylococcus spp, Parvimonas spp, Proteniphilum spp, Saccharofermentans spp, Klebsiella spp | Actinobacteria | |
Head and neck | Stenotrophomonas, Comamonadacea, Fusobacterium, Peptostreptococcus | Â |